Secondary Logo

Institutional members access full text with Ovid®

Performance of Patients with Early Parkinson Disease on an Executive and Social Cognition Battery

Esteves, Sol, MD*; Gleichgerrcht, Ezequiel, PhD; Torralva, Teresa, PhD*; Chade, Anabel, MD*; Gómez Arévalo, Gonzalo, MD*; Gershanik, Oscar, MD*; Manes, Facundo, PhD*,‡,§; Roca, María, PhD*,‡

Cognitive and Behavioral Neurology: September 2018 - Volume 31 - Issue 3 - p 142–150
doi: 10.1097/WNN.0000000000000159
Original Studies

Objective: To demonstrate the usefulness of incorporating the Executive and Social Cognition Battery (ESCB) to detect executive and social cognition deficits, which are otherwise not captured by more “classical” executive tests in early Parkinson disease (PD).

Background: PD is a neurodegenerative disorder that includes executive and social cognition deficits. While cognitive assessment in PD still relies on classical executive tasks to detect frontal deficits, these traditional tests often fail to uncover subtle, yet relevant, frontal impairment.

Methods: We evaluated 39 PD patients and 47 controls with a battery of classical executive tests and the ESCB. The ESCB includes a series of tasks that more closely resemble real-life activities and have been previously shown to be useful in detecting executive deficits in other neuropsychiatric disorders with frontal involvement.

Results: We observed that both batteries used in a complementary way yielded better results, as 15 of the 39 patients presented deficits only on some of the ESCB tests, but not on the classical battery, while 5 patients presented deficits only on some tests of the classical battery, but not on the ESCB. Fourteen patients presented deficits on some tests of either battery, and 5 patients did not present deficits on any of the tests.

Conclusions: We found that, used along with traditional neuropsychological tasks, the ESCB may be useful in providing a more comprehensive evaluation of frontal dysfunction among patients with PD, thus contributing to the early diagnosis of cognitive disorders in this patient population.

*Institute of Cognitive and Translational Neuroscience (INCyT), INECO Foundation, Favaloro University, and CONICET, Buenos Aires, Argentina

Department of Neurology, Medical University of South Carolina, Charleston, South Carolina

National Scientific and Technical Research Council, Buenos Aires, Argentina

§Australian Research Council (ACR) Centre of Excellence in Cognition and Its Disorders, Macquarie University, New South Wales, Australia

Supported in part by grants from CONICET and INECO Foundation.

The authors declare no conflicts of interest.

Correspondence: María Roca, PhD, Laboratory of Research in Neuropsychology; Institute of Cognitive and Translational Neuroscience (INCyT), INECO Foundation, Favaloro University, and CONICET, Pacheco de Melo 1860, Buenos Aires, Argentina (e-mail:

Received August 2, 2017

Accepted July 13, 2018

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved